Matthew Mintz and Merrill Goozner comment on the implications of this.
The FDA is considering lifting restrictions for off-label drug promotion
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
More in Uncategorized
Past Week
-
How smartphones are stealing your focus—and what you can do about it
-
Overcoming the curse of knowledge: Why doctors need to translate medicine [PODCAST]
-
The heartbreaking pandemic story I will never forget
-
How Earth Day can inspire better health for doctors and patients
-
Why female physicians are done asking for permission
-
Spreading hope one card at a time for doctors’ well-being [PODCAST]
-
Past 6 Months
-
How trade wars could destroy the U.S. health care system
-
How hospitals are quietly taking control of physicians
-
The silent crisis hurting pain patients and their doctors
-
How the system hunts physicians who refuse to kneel
-
Doctors don’t need yoga, they need time to smoke
-
What happened to real care in health care?
-
Recent Posts
-
Overcoming the curse of knowledge: Why doctors need to translate medicine [PODCAST]
-
Signing bonuses and taxes: What physicians should know
-
Learning to trust your body again: Healing the hidden wounds of medical training
-
Love, empathy, and the triangle of exhaustion: Why humanity must come first
-
How smartphones are stealing your focus—and what you can do about it
-
Practical advice for physicians seeking joy and well-being [PODCAST]
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
